Evidence map›Paper›PMID 31992191›Full record

ArticleBMC genomics2020

Assessment of branch point prediction tools to predict physiological branch points and their alteration by variants.

Raphaël Leman, Hélène Tubeuf, Sabine Raad, Isabelle Tournier, Céline Derambure, Raphaël Lanos, Pascaline Gaildrat, Gaia Castelain, Julie Hauchard, Audrey Killian and 22 more

Open access · goldAbstract read
In one paragraph

Article in BMC genomics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
8.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 45 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Cancer genomic profiling predicts pathogenicity ofmedRxiv : the preprint server for health sciences · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Frontiers in genetics · 2023
    Article
  17. Review
  18. Article
  19. Article
  20. Genome-wide detection of human variants that disrupt intronic branchpoints.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 8 institutions in 5 countries.

Raphaël LemanLaboratoire de Biologie Clinique et Oncologique, Centre François Baclesse, Caen, France. r.leman@baclesse.unicancer.fr.ORCID http://orcid.org/0000-0003-1978-7133
Hélène TubeufInserm U1245, Normandy Center for Genomic and Personalized Medicine, Rouen, UNIROUEN, Normandy University, Caen, France.
Sabine RaadInserm U1245, Normandy Center for Genomic and Personalized Medicine, Rouen, UNIROUEN, Normandy University, Caen, France.
Isabelle TournierInserm U1245, Normandy Center for Genomic and Personalized Medicine, Rouen, UNIROUEN, Normandy University, Caen, France.
Céline DerambureInserm U1245, Normandy Center for Genomic and Personalized Medicine, Rouen, UNIROUEN, Normandy University, Caen, France.
Raphaël LanosInserm U1245, Normandy Center for Genomic and Personalized Medicine, Rouen, UNIROUEN, Normandy University, Caen, France.
Pascaline GaildratInserm U1245, Normandy Center for Genomic and Personalized Medicine, Rouen, UNIROUEN, Normandy University, Caen, France.
Gaia CastelainInserm U1245, Normandy Center for Genomic and Personalized Medicine, Rouen, UNIROUEN, Normandy University, Caen, France.
Julie HauchardInserm U1245, Normandy Center for Genomic and Personalized Medicine, Rouen, UNIROUEN, Normandy University, Caen, France.
Audrey KillianInserm U1245, Normandy Center for Genomic and Personalized Medicine, Rouen, UNIROUEN, Normandy University, Caen, France.
Stéphanie Baert-DesurmontInserm U1245, Normandy Center for Genomic and Personalized Medicine, Rouen, UNIROUEN, Normandy University, Caen, France.
Angelina LegrosLaboratoire de Biologie Clinique et Oncologique, Centre François Baclesse, Caen, France.
Nicolas GoardonLaboratoire de Biologie Clinique et Oncologique, Centre François Baclesse, Caen, France.
Céline QuesnelleLaboratoire de Biologie Clinique et Oncologique, Centre François Baclesse, Caen, France.
Agathe RicouLaboratoire de Biologie Clinique et Oncologique, Centre François Baclesse, Caen, France.
Laurent CasteraLaboratoire de Biologie Clinique et Oncologique, Centre François Baclesse, Caen, France.
Dominique VaurLaboratoire de Biologie Clinique et Oncologique, Centre François Baclesse, Caen, France.
Gérald Le GacInserm UMR1078, Genetics, Functional Genomics and Biotechnology, Université de Bretagne Occidentale, Brest, France.
Chandran KaInserm UMR1078, Genetics, Functional Genomics and Biotechnology, Université de Bretagne Occidentale, Brest, France.
Yann FichouInserm UMR1078, Genetics, Functional Genomics and Biotechnology, Université de Bretagne Occidentale, Brest, France.
Françoise Bonnet-DorionInserm U916, Département de Pathologie, Laboratoire de Génétique Constitutionnelle, Institut Bergonié, Bordeaux, France.
Nicolas SevenetInserm U916, Département de Pathologie, Laboratoire de Génétique Constitutionnelle, Institut Bergonié, Bordeaux, France.
Marine Guillaud-BatailleService de Génétique, Institut Gustave Roussy, Villejuif, France.
Nadia Boutry-KryzaLyon Neuroscience Research Center-CRNL, Inserm U1028, CNRS UMR 5292, University of Lyon, Lyon, France.
Inès SchultzLaboratoire d'Oncogénétique, Centre Paul Strauss, Strasbourg, France.
Virginie Caux-MoncoutierService de Génétique, Institut Curie, Paris, France.
Maria RossingCentre for Genomic Medicine, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Logan C WalkerDepartment of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand.
Amanda B SpurdleDepartment of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
Claude HoudayerInserm U1245, Normandy Center for Genomic and Personalized Medicine, Rouen, UNIROUEN, Normandy University, Caen, France.
Alexandra MartinsInserm U1245, Normandy Center for Genomic and Personalized Medicine, Rouen, UNIROUEN, Normandy University, Caen, France.
Sophie KriegerLaboratoire de Biologie Clinique et Oncologique, Centre François Baclesse, Caen, France. S.KRIEGER@baclesse.unicancer.fr.
Inserm · FRCentre François Baclesse · FRInstitut Curie · FRInstitut Gustave Roussy · FRQIMR Berghofer Medical Research Institute · AUUniversité Claude Bernard Lyon 1 · FRUniversity of Copenhagen · DKUniversity of Otago · NZ

Funding

Association Nationale de la Recherche et de la Technologie (#2015/0335Fondation de France 200412859Groupement des Entreprises Françaises dans la Lutte contre le Cancer Gefluc, # R18064EENHMRC Senior Research Fellowship 1061779
6 · The paper itself

Abstract

backgroundBranch points (BPs) map within short motifs upstream of acceptor splice sites (3'ss) and are essential for splicing of pre-mature mRNA. Several BP-dedicated bioinformatics tools, including HSF, SVM-BPfinder, BPP, Branchpointer, LaBranchoR and RNABPS were developed during the last decade. Here, we evaluated their capability to detect the position of BPs, and also to predict the impact on splicing of variants occurring upstream of 3'ss.

resultsWe used a large set of constitutive and alternative human 3'ss collected from Ensembl (n = 264,787 3'ss) and from in-house RNAseq experiments (n = 51,986 3'ss). We also gathered an unprecedented collection of functional splicing data for 120 variants (62 unpublished) occurring in BP areas of disease-causing genes. Branchpointer showed the best performance to detect the relevant BPs upstream of constitutive and alternative 3'ss (99.48 and 65.84% accuracies, respectively). For variants occurring in a BP area, BPP emerged as having the best performance to predict effects on mRNA splicing, with an accuracy of 89.17%.

conclusionsOur investigations revealed that Branchpointer was optimal to detect BPs upstream of 3'ss, and that BPP was most relevant to predict splicing alteration due to variants in the BP area.

Indexed as

IntronsRNA PrecursorsRNA Splice SitesRNA SplicingAlternative SplicingComputational BiologyHumansNucleotide MotifsPosition-Specific Scoring MatricesReproducibility of ResultsRNA Processing, Post-TranscriptionalROC CurveRNA PrecursorsRNA Splice SitesBenchmarkBPPBranch pointBranchpointerHSFLaBranchoRPredictionRNARNABPSSVM-BPfinderVariants

Identifiers

PMID31992191
PMCPMC6988378
OpenAlexW3005572415

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.